
VLTO · NYSE
Consensus is $1.14 EPS for Dec 2026 across 3 estimates, ranging $1.13 to $1.15.
Veralto’s quarter ended October 2 combined solid underlying growth with a strong adjusted earnings result. Revenue of $1.509 billion was up 7.5% year over year, while core sales grew 5.1%; adjusted diluted EPS of $1.18 beat the $1.10 consensus by 7.3% and rose 19.2% from a year earlier. GAAP diluted EPS was $1.03, compared with $0.95 a year ago. Versus the prior reported quarter, revenue increased from $1.474 billion and EPS from $0.98, while operating income declined from $315 million to $298 million and net income rose from $241 million to $253 million.
The defining feature was the contrast between adjusted operating leverage and lower GAAP profitability: adjusted margin expanded 170 basis points to 25.6%, but GAAP margin contracted to 19.7% from 23.2%. Water Quality led organic growth, while Product Quality & Innovation improved sequentially. Management raised full-year adjusted EPS guidance to $4.49–$4.52 and expects fourth-quarter core sales growth to accelerate to 5.5%–6.5%. The company also emphasized acquisitions, buybacks and cost actions: it had deployed $1.1 billion on four acquisitions and repurchased $550 million of stock year to date through October 28.
Revenue increased 7.5% to $1.509 billion, with 5.1% core sales growth accounting for most of the increase. Acquisitions added 2.3 percentage points to reported growth and currency was a 0.1-point headwind. Pricing contributed 2.3% to year-over-year growth. Core growth improved from 3.8% for the first nine months, with developed markets stronger than high-growth markets: quarterly core sales rose 6.2% in developed markets and 1.6% in high-growth markets.
Adjusted operating profit was $386 million, up from $336 million a year ago, and adjusted margin widened to 25.6% from 23.9%. By contrast, GAAP operating profit fell to $298 million from $326 million despite higher sales. The comparison reflects $22 million of restructuring expense, $10 million of other strategic-initiative costs and a $39 million reduction in the tax indemnification asset recorded in operating costs. Together with higher acquisition-related amortization, these items contributed to the GAAP margin decline. The quarter also benefited from a low 7.3% effective tax rate versus 21.9% a year ago; the company attributed this largely to a $47 million net discrete tax benefit, including the related indemnification tax adjustment. GAAP net earnings increased to $253 million from $239 million.
Veralto raised full-year core sales growth guidance to 4.2%–4.5% from 4.0%–4.5%, and now expects adjusted operating margin expansion of approximately 50 basis points, versus the previous range of 25–50 basis points. Adjusted diluted EPS guidance increased to $4.49–$4.52 from $4.35–$4.43, implying 15%–16% growth over the prior year. Free cash flow conversion is now expected to exceed 105% of GAAP net earnings, up from the prior expectation of more than 100%. Fourth-quarter guidance calls for adjusted EPS of $1.13–$1.16 and adjusted operating margin of approximately 24.5%, broadly in line with the prior-year quarter.
Through October 28, the company reported $1.1 billion invested in four strategic bolt-on acquisitions: In-Situ, GlobalVision, Alfaa UV and Cleanwater1. Cleanwater1 closed on October 5, after the quarter, for $465 million and will join Water Quality; the business has an installed base of about 25,000 units in municipal and industrial water applications. The company also repurchased $550 million of shares year to date, or 2.4% of shares outstanding, with $227 million remaining under its $750 million authorization. The cost optimization program is expected to deliver $10–$15 million of savings in 2026; total restructuring charges are estimated at $85–$105 million through its expected completion by the end of 2028.
Operating cash flow of $323 million compared with $270 million a year ago, while free cash flow increased to $304 million from $258 million after $19 million of capital expenditures. Free cash flow was $328 million in the prior reported quarter. For the first nine months, operating cash flow was $845 million, up from $766 million, while cash used for acquisitions was $683 million. Cash and equivalents stood at $1.785 billion at October 2; total debt was $2.920 billion, including $249 million of commercial paper issued to help fund the subsequent Cleanwater1 acquisition.